Vistagen Therapeutics, Inc. · NASDAQ:VTGN

Nantahala Capital Management, LLC's stake in Vistagen Therapeutics, Inc. fell to 4.71% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 13, 2026

Nantahala Capital Management, LLC's stake in Vistagen Therapeutics, Inc. fell to 4.71%, 1,953,045 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).

Stake
4.71%
Shares
1,953,045
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Nantahala Capital Management, LLC4.71%1,953,045
Wilmot B. Harkey4.71%1,953,045
Daniel Mack4.71%1,953,045

Source

View original at SEC

Related